Last reviewed · How we verify

NCT06830980

Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH

Recruiting now NA Last updated 24 October 2025
What this trial tests

NA trial testing intermittent theta burst stimulation (iTBS) in Methamphetamine Use Disorders in 30 participants. Currently enrolling.

Timeline
11 March 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorGopalkumar Rakesh
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date11 March 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Gopalkumar Rakesh

Who can join

Adults 18 to 65, any sex, with Methamphetamine Use Disorders or HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to learn more about how accelerated theta burst stimulation affects methamphetamine craving and brain activity. Theta burst stimulation is a unique transcranial magnetic stimulation (TMS) paradigm that is efficient and potent.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of intermittent theta burst stimulation (iTBS)

Trials testing the same drug.

Other Gopalkumar Rakesh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06830980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing